1. 1373PIdentification of subjects with locally advanced lung cancer who are likely to respond to standard-of-care chemoradiotherapy by a longitudinal monitoring of circulating tumor DNA (ctDNA) using a comprehensive ultra-sensitive NGS assay. (23rd October 2018) Authors: Vitazka, P; Tikoo, N; Balasubramanyam, A; Xi, L; Yaung, S; Kwok, E; Lovejoy, A; Klass, D; Heibeck, M; Probst, K; Rehfeldt, A; Meldgaard, E; Madsen, A; Clement, M; Palma, J; Sorensen, B; Meldgaard, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1426PLongitudinal plasma monitoring of subjects treated with EGFR-TKIs allows better understanding of evolution of acquired resistance and can inform optimal treatment strategies. (23rd October 2018) Authors: Palma, J; Vitazka, P; Tikoo, N; Balasubramanyam, A; Xi, L; Yaung, S; Kwok, E; Lovejoy, A; Klass, D; Heibeck, M; Probst, K; Rehfeldt, A; Meldgaard, E; Madsen, A; Clement, M; Sorensen, B; Meldgaard, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗